Bay Street News, 2023

FLORHAM PARK, N.J., Dec. 19, 2023 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused […]

LEHI, Utah, Dec. 19, 2023 (GLOBE NEWSWIRE) — Nature’s Sunshine Products, Inc. (Nasdaq: NATR) (Nature’s Sunshine), a leading natural health […]

Vancouver, BC, Dec. 19, 2023 (GLOBE NEWSWIRE) — Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQX: SYHBF) (Frankfurt: SC1P) (“Skyharbour” or the […]

Reports more than 60% increase in total RELI Exchange policies followingonboarding of Fortman Insurance under new “One-Firm” approach Adds two […]

NEW YORK, Dec. 19, 2023 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (“INBS” or the “Company”) (Nasdaq: INBS), a medical technology […]

BOSTON and ATLANTA, Dec. 19, 2023 (GLOBE NEWSWIRE) — Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a clinical-stage pharmaceutical […]

MIAMI, FL, Dec. 19, 2023 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on […]

Drawn From A Year’s Worth Of Proprietary Polling, Xometry’s 2024 Predictions Show An Industry Embracing High-Tech Tools And Talent To […]

NORSE EIGHT study on track to commence in Q1 2024 Resubmission of ONS-5010 Biologics License Application (BLA) in the U.S. […]

BERKELEY, Calif. and MAINZ, Germany, Dec. 19, 2023 (GLOBE NEWSWIRE) — Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), […]